Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

UK-240455

🥰Excellent
Catalog No. T13248Cas No. 178908-09-3

UK-240455 is a potent and selective N-methyl-D-aspartic acid (NMDA) glycine receptor antagonist with neuroprotective effects and improvements in motor function in Parkinson's disease models, making it a potential candidate for Parkinson's disease treatment.

UK-240455

UK-240455

🥰Excellent
Purity: 99.83%
Catalog No. T13248Cas No. 178908-09-3
UK-240455 is a potent and selective N-methyl-D-aspartic acid (NMDA) glycine receptor antagonist with neuroprotective effects and improvements in motor function in Parkinson's disease models, making it a potential candidate for Parkinson's disease treatment.
Pack SizePriceAvailabilityQuantity
1 mg332 €In Stock
5 mg786 €In Stock
10 mg1.073 €In Stock
25 mg1.510 €In Stock
50 mg1.881 €In Stock
100 mg2.375 €In Stock
500 mg4.655 €In Stock
1 mL x 10 mM (in DMSO)680 €In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "UK-240455"

Select Batch
Purity:99.83%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
UK-240455 is a potent and selective N-methyl-D-aspartic acid (NMDA) glycine receptor antagonist with neuroprotective effects and improvements in motor function in Parkinson's disease models, making it a potential candidate for Parkinson's disease treatment.
In vivo
After i.v. administration of UK-240455 to male rats, UK-240455 exhibits a clearance of 12 mL/min/kg and a volume of distribution of 0.4 L/kg. The plasma concentration of UK-240455 shows a decrease with an apparent half-life of 0.4 h. The analysis of urine (0 to 24 h) reveals that 57% of the administered dose is excreted unchanged. Thus, the urine clearance rate of UK-240455 in rats amounts to 7 mL/min/kg. Upon oral administration to male rats, the apparent elimination half-life of UK-240455 from plasma was observed to be 1.6 hours.[1]
Chemical Properties
Molecular Weight368.19
FormulaC11H11Cl2N3O5S
Cas No.178908-09-3
SmilesN(CCO)(S(C)(=O)=O)C1=C2C(=CC(Cl)=C1Cl)NC(=O)C(=O)N2
Relative Density.1.686 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 12 mg/mL (32.59 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.7160 mL13.5799 mL27.1599 mL135.7995 mL
5 mM0.5432 mL2.7160 mL5.4320 mL27.1599 mL
10 mM0.2716 mL1.3580 mL2.7160 mL13.5799 mL
20 mM0.1358 mL0.6790 mL1.3580 mL6.7900 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy UK-240455 | purchase UK-240455 | UK-240455 cost | order UK-240455 | UK-240455 chemical structure | UK-240455 in vivo | UK-240455 formula | UK-240455 molecular weight